Drug
Tetracaine 7 Lidocaine 7
Tetracaine 7 Lidocaine 7: highest development phase Post-Market, developed by Galderma. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Galderma
Trials
| Drug | Phase | Indication |
|---|---|---|
| tetracaine 7% / lidocaine 7% cream (Pliaglis® Cream) NCT00716443 | Post-Market | Nasolabial Folds |
Latest
No recent events.
Follow Tetracaine 7 Lidocaine 7 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.